|
TBC1D2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.828450E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.409600E-02 |
| Normal-vs-Stage2 |
7.210600E-01 |
| Normal-vs-Stage3 |
9.664200E-01 |
| Normal-vs-Stage4 |
2.717000E-01 |
| Stage1-vs-Stage2 |
9.682100E-02 |
| Stage1-vs-Stage3 |
1.170620E-01 |
| Stage1-vs-Stage4 |
9.395000E-01 |
| Stage2-vs-Stage3 |
7.477600E-01 |
| Stage2-vs-Stage4 |
3.221200E-01 |
| Stage3-vs-Stage4 |
3.270800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.674200E-02 |
| Normal-vs-AfricanAmerican |
6.336400E-01 |
| Normal-vs-Asian |
6.659400E-01 |
| Caucasian-vs-AfricanAmerican |
3.083800E-01 |
| Caucasian-vs-Asian |
4.115600E-01 |
| AfricanAmerican-vs-Asian |
5.978200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.815800E-02 |
| Normal-vs-Female |
2.463600E-01 |
| Male-vs-Female |
3.202200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.954400E-01 |
| Normal-vs-Extreme_Weight |
2.518500E-02 |
| Normal-vs-Obese |
6.907200E-01 |
| Normal-vs-Extreme_Obese |
2.535300E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.670350E-01 |
| Normal_Weight-vs-Obese |
8.801400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.517500E-03 |
| Extreme_Weight-vs-Obese |
9.339900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.006200E-02 |
| Obese-vs-Extreme_Obese |
2.478100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.456300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.682200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.687700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.641700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.703800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.900200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.274180E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.493900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.381830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.427400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.710350E-02 |
| Normal-VS-Type2 PRCC |
4.180800E-01 |
| Normal-VS-KIRP CIMP |
9.182500E-04 |
| Normal-VS-Unclassified PRCC |
4.132200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.135050E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.59024999999424E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.074190E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.236200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.611200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.110180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.040230E-01 |
| Normal-vs-N1 |
5.592400E-01 |
| Normal-vs-N2 |
9.199800E-01 |
| N0-vs-N1 |
5.522000E-02 |
| N0-vs-N2 |
4.603600E-01 |
| N1-vs-N2 |
8.605000E-01 |
|
|
